Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Rosiglitazone may be useful for the treatment of antiretroviral therapy-associated lipoatrophy, but an association with cardiovascular disease (CVD) has been questioned in diabetics. We evaluated rosiglitazone's effect on surrogate markers of CVD in HIV-infected individuals with lipoatrophy. HI...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Tungsiripat, Marisa, El-Bejjani, Dalia, Rizk, Nesrine, Dogra, Vikram, O'Riordan, Mary Ann, Ross, Allison C., Hileman, Corrilynn, Storer, Norma, Harrill, Danielle, McComsey, Grace A.
Формат: Artigo
Язык:Inglês
Опубликовано: Mary Ann Liebert, Inc. 2011
Предметы:
Preclinical Studies/Drug Development
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064528/
https://ncbi.nlm.nih.gov/pubmed/20969457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0187
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы